Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Wednesday, September 30, 2020.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2021 (2020-09-30): 37.83%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
9.56%
RETURN ON EQUITY (ROE) AVG 3Y
10.14%
RETURN ON EQUITY (ROE) AVG 5Y
17.02%
RETURN ON EQUITY (ROE) AVG 10Y
18.39%
RETURN ON EQUITY (ROE) AVG 15Y
16.97%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
McKesson Corporation
Market Cap
$103.02B
Return on Equity (ROE)
N/A
TTM Avg
9.56%
3Y Avg
10.14%
5Y Avg
17.02%
Market Cap
$107.67B
Return on Equity (ROE)
15.55%
TTM Avg
14.50%
3Y Avg
15.05%
5Y Avg
14.30%
Market Cap
$93.25B
Return on Equity (ROE)
N/A
TTM Avg
-171.53%
3Y Avg
-210.62%
5Y Avg
-155.29%
Market Cap
$115.07B
Return on Equity (ROE)
6.16%
TTM Avg
4.23%
3Y Avg
6.35%
5Y Avg
7.74%
Market Cap
$89.71B
Return on Equity (ROE)
11.06%
TTM Avg
13.69%
3Y Avg
14.71%
5Y Avg
14.93%
Market Cap
$119.26B
Return on Equity (ROE)
10.41%
TTM Avg
9.71%
3Y Avg
8.51%
5Y Avg
8.44%
Market Cap
$81.10B
Return on Equity (ROE)
13.65%
TTM Avg
14.72%
3Y Avg
15.95%
5Y Avg
23.11%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| McKesson Corporation (MCK) | $103.02B | N/A | 9.56% | 10.14% | 17.02% |
| Sanofi (SNY)vs › | $103.70B | 5.82% | 9.06% | 9.15% | 10.86% |
| GSK plc (GSK)vs › | $102.07B | 27.67% | 26.90% | 55.97% | 45.70% |
| Stryker Corporation (SYK)vs › | $107.67B | 15.55% | 14.50% | 15.05% | 14.30% |
| HCA Healthcare, Inc. (HCA)vs › | $93.25B | N/A | -171.53% | -210.62% | -155.29% |
| CVS Health Corp. (CVS)vs › | $115.07B | 6.16% | 4.23% | 6.35% | 7.74% |
| Elevance Health Inc. (ELV)vs › | $89.71B | 11.06% | 13.69% | 14.71% | 14.93% |
| Medtronic plc (MDT)vs › | $119.26B | 10.41% | 9.71% | 8.51% | 8.44% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $81.10B | 13.65% | 14.72% | 15.95% | 23.11% |
| Bristol-Myers Squibb Company (BMY)vs › | $127.88B | 41.59% | -8.30% | 7.76% | 4.45% |
ROE
N/A
ROA
5.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2020-09-30 | 37.83% |
| 2020-06-30 | 16.91% |
| 2020-03-31 | 17.67% |
| 2019-12-31 | -14.85% |
| 2019-09-30 | -9.78% |
| 2019-06-30 | 7.56% |
| 2019-03-31 | 0.42% |
| 2018-12-31 | -3.44% |
| 2018-09-30 | 1.27% |
| 2018-06-30 | -4.04% |
| 2018-03-31 | 0.66% |
| 2017-12-31 | 40.90% |
| 2017-09-30 | 40.67% |
| 2017-06-30 | 42.81% |
| 2017-03-31 | 45.73% |
| 2016-12-31 | 24.92% |
| 2016-09-30 | 20.27% |
| 2016-06-30 | 24.05% |
| 2016-03-31 | 25.30% |
| 2015-12-31 | 22.07% |
| 2015-09-30 | 20.45% |
| 2015-06-30 | 18.63% |
| 2015-03-31 | 18.45% |
| 2014-12-31 | 18.88% |
| 2014-09-30 | 14.63% |
| 2014-06-30 | 13.83% |
| 2014-03-31 | 14.82% |
| 2013-12-31 | 14.34% |
| 2013-09-30 | 17.34% |
| 2013-06-30 | 18.66% |
| 2013-03-31 | 18.93% |
| 2012-12-31 | 20.92% |
| 2012-09-30 | 20.76% |
| 2012-06-30 | 20.78% |
| 2012-03-31 | 20.54% |
| 2011-12-31 | 17.49% |
| 2011-09-30 | 16.29% |
| 2011-06-30 | 17.20% |
| 2011-03-31 | 16.65% |
| 2010-12-31 | 15.93% |
| 2010-09-30 | 19.06% |
| 2010-06-30 | 18.51% |
| 2010-03-31 | 16.77% |
| 2009-12-31 | 16.79% |
| 2009-09-30 | 12.65% |
| 2009-06-30 | 13.97% |
| 2009-03-31 | 13.29% |
| 2008-12-31 | 13.77% |
| 2008-09-30 | 16.85% |
| 2008-06-30 | 15.86% |
| 2008-03-31 | 16.17% |
| 2007-12-31 | 14.45% |
| 2007-09-30 | 15.38% |
| 2007-06-30 | 14.97% |
| 2007-03-31 | 14.55% |
| 2006-12-31 | 14.37% |
| 2006-09-30 | 13.95% |
| 2006-06-30 | 12.93% |
| 2006-03-31 | 12.71% |
| 2005-12-31 | 13.37% |
| 2005-09-30 | -1.17% |
| 2005-06-30 | -2.60% |
| 2005-03-31 | -2.97% |
| 2004-12-31 | -4.09% |
| 2004-09-30 | 10.56% |
| 2004-06-30 | 12.07% |
| 2004-03-31 | 12.52% |
| 2003-12-31 | 12.30% |
| 2003-09-30 | 12.90% |
| 2003-06-30 | 12.70% |